Citation Impact
Citing Papers
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study
2006
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen‐negative patients
1998
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus
1997
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Pathogenesis of hepatitis B virus infection
2010
Hepatitis C Virus Infection
2001 Standout
Wearable biosensors for healthcare monitoring
2019 Standout
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study
2002
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Molecular biology of hepatitis B virus e antigen
1997
Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen‐negative chronic hepatitis B virus‐infected patients
2002
Diagnosis and treatment of autoimmune hepatitis
2002
Cytotoxic T cells and viral hepatitis.
1997
Hepatitis C virus replication in ‘autoimmune’ chronic hepatitis
1991 StandoutNobel
Diagnosis and Management of Autoimmune Hepatitis
2010
Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity
2000
Treatment of Chronic Hepatitis D with Interferon Alfa-2a
1994
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
2000
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
Hepatitis B virus infection
2009 Standout
Chronic hepatitis B
2001
Evidence for a dynamic host‐parasite relationship in e‐negative hepatitis B carriers
2002
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
2005 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Hepatitis B e antigen-negative chronic hepatitis B
2001
Hepatitis B virus genotypes in the United States: results of a nationwide study
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease
1992
Liver/Kidney Microsome Antibody Type 1 and Hepatitis C Virus Infection
1992
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals
2000
Mutations in the Basic Core Promotor and the Precore Region of Hepatitis B Virus and Their Selection in Children With Fulminant and Chronic Hepatitis B
1999
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
2008
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
The natural history of chronic hepatitis B virus infection #
2009
Chronic hepatitis B: Update 2009 #
2009 Standout
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis
1997
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
2008
High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy
1999 StandoutNobel
Outcome of Hepatitis B e Antigen–Negative Chronic Hepatitis B on Long-Term Nucleos(t)ide Analog Therapy Starting With Lamivudine *
2005
Regulation of type I interferon responses
2013 Standout
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen
2000
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen
1989
Prevalence of Hbv Precore/Core Promoter Variants in the United States
2003
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
2000
Exploring the Biological Basis of Hepatitis B E Antigen in Hepatitis B Virus Infection
2003
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
2006
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Hepatitis B virus induces RNR-R2 expression via DNA damage response activation
2015 StandoutNobel
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
2007
Hepatocellular Carcinoma
2011 Standout
An update: salivary hormones and physical exercise
2010
Clinical Aspects of the Interactions Between Human Immunodeficiency Virus and the Hepatotropic Viruses
1994
Chronic Hepatitis B: Current Testing Strategies
2006
Meeting report: International autoimmune hepatitis group
1993
Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis δ Antigen
1998 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview
2003
The Free Radical Theory of Aging Matures
1998 Standout
A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen
2004
Long term response to therapy of chronic anti-HBe–positive Hepatitis B is poor independent of type and schedule of interferon
1999
The clinical significance of core promoter and precore mutations during the natural course and interferon therapy in patients with chronic hepatitis B
1999
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion
2002
Meta‐analysis: antiviral treatment for hepatitis D
2012
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
2006
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Recurrent Staphylococcal Cellulitis and Subcutaneous Abscesses in a Child with Autoantibodies against IL-6
2008
Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus
1999 StandoutNobel
Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s
1998 Standout
THE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
1994
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
2005
M4 and M9 Antibodies in the Overlap Syndrome of Primary Biliary Cirrhosis and Chronic Active Hepatitis: Epitopes or Epiphenomena?
1992
Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesis
1993
Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C
1993
Versatile and Amplified Biosensing through Enzymatic Cascade Reaction by Coupling Alkaline Phosphatase in Situ Generation of Photoresponsive Nanozyme
2015
Activation of the grp78 and grp94 Promoters by Hepatitis C Virus E2 Envelope Protein
1999 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic
1996
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of M. Baldi being referenced
Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a
1994
A new hepatitis C virus‐like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatase serum levels
1997
Hepatitis C virus infection and disease
1993
Antibodies to Hepatitis C Virus in Kidney Transplantation
1992
Detection of hepatitis C virus RNA by reverse-transcriptase and polymerase chain reaction: clinical applications of quantitative analysis
1994
Changes in awakening Cortisol response and midnight salivary Cortisol are sensitive markers of strenuous training-induced fatigue
2008
Role of hepatitis delta virus infection in hepatocellular carcinoma
1991
Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM)
1991
Chronic HDV (hepatitis delta virus) hepatitis
1988
The natural history of chronic delta hepatitis.
1987
Treatment of chronic type B hepatitis, positive for the antibody to hepatitis B "e" antigen with alpha-2A-interferon.
1988
Clinical relevance of anti-interferon antibodies in the serum of chronic hepatitis C patients treated with interferon-alpha.
1997
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.
1991